These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 32669588)

  • 1. Disparate survival of late-stage male oropharyngeal cancer in Appalachia.
    Papenberg BW; Allen JL; Markwell SM; Interval ET; Montague PA; Johnson CJ; Weed SA
    Sci Rep; 2020 Jul; 10(1):11612. PubMed ID: 32669588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and survival for oropharynx and non-oropharynx head and neck cancers among veterans living with HIV.
    Mazul AL; Hartman C; Kramer J; White DL; Royse K; Raychaudhury S; Sandulache V; Ahmed ST; Richardson P; Sikora AG; Chiao E
    Cancer Med; 2020 Dec; 9(24):9326-9335. PubMed ID: 33094910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synchronous cancers in patients with head and neck cancer: risks in the era of human papillomavirus-associated oropharyngeal cancer.
    Jain KS; Sikora AG; Baxi SS; Morris LG
    Cancer; 2013 May; 119(10):1832-7. PubMed ID: 23423883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time-varying survival effects for squamous cell carcinomas at oropharyngeal and nonoropharyngeal head and neck sites in the United States, 1973-2015.
    Brouwer AF; He K; Chinn SB; Mondul AM; Chapman CH; Ryser MD; Banerjee M; Eisenberg MC; Meza R; Taylor JMG
    Cancer; 2020 Dec; 126(23):5137-5146. PubMed ID: 32888317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Health System and Policy Implications of Changing Epidemiology for Oral Cavity and Oropharyngeal Cancers in the United States From 1995 to 2016.
    LeHew CW; Weatherspoon DJ; Peterson CE; Goben A; Reitmajer K; Sroussi H; Kaste LM
    Epidemiol Rev; 2017 Jan; 39(1):132-147. PubMed ID: 28402398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the burden of HPV-related cancers in Appalachia.
    Reiter PL; Fisher JL; Hudson AG; Tucker TC; Plascak JJ; Paskett ED
    Hum Vaccin Immunother; 2013 Jan; 9(1):90-6. PubMed ID: 23143774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The epidemiology of head and neck squamous cell carcinoma in The Netherlands during the era of HPV-related oropharyngeal squamous cell carcinoma. Is there really evidence for a change?
    van Monsjou HS; Schaapveld M; van den Brekel MW; Balm AJ
    Oral Oncol; 2015 Oct; 51(10):901-7. PubMed ID: 26216340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relation between the level of lymph node metastasis and survival in locally advanced head and neck squamous cell carcinoma.
    Xing Y; Zhang J; Lin H; Gold KA; Sturgis EM; Garden AS; Lee JJ; William WN
    Cancer; 2016 Feb; 122(4):534-45. PubMed ID: 26554754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human papilloma virus status evaluation and survival description in selected oropharyngeal and laryngeal squamous cell carcinoma patients from Hungary.
    Reka Fejer E; Abram Z; Zs Egyed J; Voidazan S; Toth E; Szentirmay Z; Kasler M
    J BUON; 2016; 21(1):168-74. PubMed ID: 27061545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TRAF3/CYLD mutations identify a distinct subset of human papillomavirus-associated head and neck squamous cell carcinoma.
    Hajek M; Sewell A; Kaech S; Burtness B; Yarbrough WG; Issaeva N
    Cancer; 2017 May; 123(10):1778-1790. PubMed ID: 28295222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival outcomes by high-risk human papillomavirus status in nonoropharyngeal head and neck squamous cell carcinomas: A propensity-scored analysis of the National Cancer Data Base.
    Tian S; Switchenko JM; Jhaveri J; Cassidy RJ; Ferris MJ; Press RH; Pfister NT; Patel MR; Saba NF; McDonald MW; Higgins KA; Yu DS; Curran WJ; Gillespie TW; Beitler JJ
    Cancer; 2019 Aug; 125(16):2782-2793. PubMed ID: 31012957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oropharyngeal cancer as a driver of racial outcome disparities in squamous cell carcinoma of the head and neck: 10-year experience at the University of Maryland Greenebaum Cancer Center.
    Zandberg DP; Liu S; Goloubeva O; Ord R; Strome SE; Suntharalingam M; Taylor R; Morales RE; Wolf JS; Zimrin A; Lubek JE; Schumaker LM; Cullen KJ
    Head Neck; 2016 Apr; 38(4):564-72. PubMed ID: 25488341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papillomavirus (HPV) 16 and the prognosis of head and neck cancer in a geographical region with a low prevalence of HPV infection.
    López RV; Levi JE; Eluf-Neto J; Koifman RJ; Koifman S; Curado MP; Michaluart-Junior P; Figueiredo DL; Saggioro FP; de Carvalho MB; Kowalski LP; Abrahão M; de Góis-Filho F; Tajara EH; Waterboer T; Boffetta P; Brennan P; Wünsch-Filho V
    Cancer Causes Control; 2014 Apr; 25(4):461-71. PubMed ID: 24474236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gender and race interact to influence survival disparities in head and neck cancer.
    Mazul AL; Naik AN; Zhan KY; Stepan KO; Old MO; Kang SY; Nakken ER; Puram SV
    Oral Oncol; 2021 Jan; 112():105093. PubMed ID: 33232879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Classical risk factors, but not HPV status, predict survival after chemoradiotherapy in advanced head and neck cancer patients.
    Descamps G; Karaca Y; Lechien JR; Kindt N; Decaestecker C; Remmelink M; Larsimont D; Andry G; Hassid S; Rodriguez A; Khalife M; Journe F; Saussez S
    J Cancer Res Clin Oncol; 2016 Oct; 142(10):2185-96. PubMed ID: 27370781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The connection between human papillomavirus and oropharyngeal squamous cell carcinomas in the United States: implications for dentistry.
    Cleveland JL; Junger ML; Saraiya M; Markowitz LE; Dunne EF; Epstein JB
    J Am Dent Assoc; 2011 Aug; 142(8):915-24. PubMed ID: 21804058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and Risk of Second Primary Malignant Neoplasm After a First Head and Neck Squamous Cell Carcinoma.
    Adjei Boakye E; Buchanan P; Hinyard L; Osazuwa-Peters N; Schootman M; Piccirillo JF
    JAMA Otolaryngol Head Neck Surg; 2018 Aug; 144(8):727-737. PubMed ID: 30027284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of human papillomavirus in head and neck cancers at tertiary care centers in the United States over time.
    Scott-Wittenborn N; D'Souza G; Tewari S; Rooper L; Troy T; Drake V; Bigelow EO; Windon MJ; Ryan WR; Ha PK; Kiess AP; Miles B; Westra WH; Mydlarz WK; Eisele DW; Fakhry C
    Cancer; 2022 May; 128(9):1767-1774. PubMed ID: 35132635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ERCC1 protein expression is associated with differential survival in oropharyngeal head and neck squamous cell carcinoma.
    Patel MR; Zhao N; Ang MK; Stadler ME; Fritchie K; Weissler MC; Zanation AM; Harris SL; Funkhouser WK; Olshan AF; Shores CG; Hayes DN
    Otolaryngol Head Neck Surg; 2013 Oct; 149(4):587-95. PubMed ID: 23846458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case-matching analysis of head and neck squamous cell carcinoma in racial and ethnic minorities in the United States--possible role for human papillomavirus in survival disparities.
    Schrank TP; Han Y; Weiss H; Resto VA
    Head Neck; 2011 Jan; 33(1):45-53. PubMed ID: 20848419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.